Skip to main content

Table 2 Forearm blood flow

From: Endothelial function in migraine: a cross-sectional study

  Control subjects (n = 16) Migraine patients (n = 16)
Sodium nitroprusside dose, μg.min-1.dL-1 forearm 0 0.2 0.4 0.8 0 0.2 0.4 0.8
   non-infused arm 2.0 ± 0.9 1.9 ± 0.7 1.8 ± 0.8 1.8 ± 0.8 2.0 ± 0.5 2.0 ± 0.6 2.1 ± 0.8 1.9 ± 0.6
   infused arm 2.0 ± 0.5 8.6 ± 3.5 10.9 ± 4.2 14.5 ± 5.9* 2.1 ± 0.5 8.7 ± 2.9 12.1 ± 4.6 16.5 ± 6.2*
Substance P dose, pmol.min-1.dL-1 forearm 0 0.2 0.4 0.8 0 0.2 0.4 0.8
   non-infused arm 1.8 ± 0.8 1.8 ± 0.7 1.8 ± 0.7 1.9 ± 0.8 2.0 ± 0.6 1.9 ± 0.6 2.1 ± 0.6 2.0 ± 0.6
   infused arm 2.2 ± 0.7 5.5 ± 2.2 6.9 ± 2.5 8.7 ± 3.8* 2.5 ± 0.7 5.1 ± 1.2 6.5 ± 1.8 8.4 ± 2.5*
L-NMMA dose, μmol.min-1.dL-1 forearm 0 0.1 0.2 0.4 0 0.1 0.2 0.4
   non-infused arm 1.7 ± 0.5 1.8 ± 0.7 1.9 ± 0.9 1.9 ± 0.8 2.1 ± 0.5 1.9 ± 0.6 2.1 ± 0.6 2.4 ± 0.8
   infused arm 2.0 ± 0.5 1.7 ± 0.4 1.6 ± 0.4 1.4 ± 0.4* 2.5 ± 0.6 2.0 ± 0.5 1.9 ± 0.6 1.9 ± 0.6*
  1. Data are expressed as absolute blood flows (ml.min-1.dL-1 forearm); *P < 0.001 (ANOVA)